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Abstract
Mitochondrial dysfunction is believed to participate in Hunt-
ington’s disease (HD) pathogenesis. Here we compare the
bioenergetic behavior of forebrain mitochondria isolated from
different transgenic HD mice (R6/2, YAC128 and Hdh150
knock-in) and wild-type littermates with the first determination
of in situ respiratory parameters in intact HD striatal neurons.
We assess the Ca2+-loading capacity of isolated mitochondria
by steady Ca2+-infusion. Mitochondria from R6/2 mice (12–
13 weeks) and 12 months YAC128, but not homozygous or
heterozygous Hdh150 knock-in mice (15–17 weeks), exhibit
increased Ca2+-loading capacity when compared with
respective wild-type littermates. In situ mitochondria in intact
striatal neurons show high respiratory control. Moreover,
moderate expression of full-length mutant huntingtin (in
Hdh150 knock-in heterozygotes) does not significantly impair
mitochondrial respiration in unstimulated neurons. However,
when challenged with energy-demanding stimuli (NMDA-
receptor activation in pyruvate-based media to accentuate the
mitochondria role in Ca2+-handling), Hdh150 neurons are
more vulnerable to Ca2+-deregulation than neurons from their
wild-type littermates. These results stress the importance of
assessing HD mitochondrial function in the cellular context.
Keywords: calcium, excitotoxicity, Huntington’s disease,
in situ respiration, mitochondria, striatal neurons.
J. Neurochem. (2007) 101, 241–249.
Huntington’s disease (HD) is a hereditary neurodegenerative
disorder caused by a mutation in the gene encoding
huntingtin (Htt). Mutant Htt contains an abnormal polyglu-
tamine (polyQ) expansion, responsible for deleterious effects
(HDCRG 1993). Despite similar expression levels through-
out the brain, mutant Htt selectively targets striatal neurons,
with the cerebral cortex being affected later in the disease
(Vonsattel and DiFiglia 1998). Mitochondrial dysfunction
likely contributes to HD pathogenesis (Beal 2005), and may
underlie the selective neuronal degeneration.
Mitochondrial dysfunction in HD was proposed to stem
from a direct interaction with mutant Htt (Panov et al.
2002), decreasing mitochondrial Ca2+-loading capacity and
thus rendering neurons more vulnerable to Ca2+-mediated
excitotoxicity. However, studies of mitochondrial Ca2+-
loading capacity in HD have provided conﬂicting results.
Decreased Ca2+-loading capacity was observed in mito-
chondria isolated from immortalized lymphocytes
(lymphoblasts) of HD patients, brains of YAC72 HD
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mice (Panov et al. 2002), and livers of knock-in HD mice
(Choo et al. 2004). In contrast, increased Ca2+-loading
capacity was observed in isolated brain mitochondria from
R6/2 and knock-in HD mice (Brustovetsky et al. 2005).
Hence, changes in the Ca2+-loading capacity of HD
mitochondria remain controversial and thus require further
evaluation. Moreover, as most functional studies have
been performed with mitochondria isolated from their
cellular context, how HD affects in situ mitochondrial
function, namely in the vulnerable striatal neurons,
remains largely unknown.
Mitochondria can only accumulate Ca2+ until the onset
of permeability transition (PT). Because experimental
conditions strongly inﬂuence PT onset (Chalmers and
Nicholls 2003) and may account for some of the discrep-
ancies in the literature concerning the Ca2+-loading capa-
city of HD mitochondria, in the present work, we adopt
strategies to study mitochondrial Ca2+-loading capacity
independently from other potential bioenergetic differences.
Thus, Ca2+ was slowly infused (Zoccarato and Nicholls
1982) into a dilute mitochondrial suspension supplemented
with adenine nucleotides. A previous study with rat brain
mitochondria (Chalmers and Nicholls 2003) showed that
this provided a highly reproducible measure of Ca2+-
loading capacity by minimizing bioenergetic demands on
the mitochondria that result in depolarization or NAD(P)H
oxidation.
In the present study, we assess the Ca2+-loading capacities
of forebrain mitochondria isolated from three different
transgenic HD mouse models. We ﬁnd an increased Ca2+-
loading capacity in mitochondria from R6/2 and YAC128
mice, but not in those from homozygous or heterozygous
Hdh150 knock-in mice. Having failed to detect Ca2+-
handling abnormalities with isolated mitochondria from
knock-in mice, we tested for selective mitochondrial dys-
function in intact striatal neurons that might have been
concealed in the mixture of neuronal and glial mitochondria
isolated from the forebrain.
In this study, we present the ﬁrst determination of in situ
mitochondria respiratory function in intact HD striatal
neurons, using a previously described technique (Jekabsons
and Nicholls 2004) that avoids many of the artifacts inherent
to isolated mitochondrial preparations. We ﬁnd that in situ
mitochondria show surprisingly high respiratory control, and
that moderate expression of mutant Htt (in Hdh150 knock-in
heterozygous) does not signiﬁcantly impair mitochondrial
respiration, at least in resting young neurons. However, when
we challenge in situ mitochondria with high Ca2+, by
transiently activating NMDA receptors, we ﬁnd that Hdh150
striatal neurons fail to reestablish Ca2+ homeostasis in higher
proportion, when compared with neurons from wild-type
littermates. These results stress the importance of assessing
HD mitochondria function in situ, i.e., in the appropriate
cellular context.
Materials and methods
Materials
Calcium Green 5 N (CaG5 N), tetramethylrhodamine methyl ester
(TMRM+) and Fluo-5F AM were from Molecular Probes (Eugene,
OR, USA). Culture media and supplements were purchased from
Invitrogen (Carlsbad, CA, USA). NMDA, (5R,10S)-(+)-5-methyl-
10,11-dihydro [a,d] cyclohepten -5,10-imine hydrogen maleate,
myxothiazol, oligomycin, rotenone, carbonylcyanide-p-(triﬂuoro-
methoxyphenyl) hydrazone (FCCP) and other reagents were from
Sigma (St. Louis, MO, USA).
Mouse forebrain mitochondria
Transgenic mice
All procedures involving animals were performed in accordance
with the Institutional Animal Care and Use Committee guidelines.
Twelve-to-thirteen-week-old R6/2 (Mangiarini et al. 1996), 52–
55 week-old YAC128 (Slow et al. 2003) and 15–17 week-old
Hdh150 knock-in HD transgenic mice (Lin et al. 2001) and
respective wild-type littermates (backgrounds: B5CBAF1/J, FVB/
N and C57BL/6 J, respectively) were used in this study. R6/2 mice
express a short N-terminal fragment of human Htt with150 polyQ,
in addition to wild-type mouse Htt (Mangiarini et al. 1996),
presenting rapid disease onset and early death when compared with
HD mice expressing full-length Htt (Hickey and Chesselet 2003).
YAC128 mice (line 53) express full-length human Htt with 128
polyQ by means of a yeast artiﬁcial chromosome (YAC), in addition
to wild-type mouse Htt (Slow et al. 2003). Knock-in mice are a
faithful reproduction of the HD genotype as the elongated polyQ
tracts are encoded within the correct context of the mouse Hdh gene
(Hickey and Chesselet 2003), homologous to the human HD gene.
Hdh150 knock-in mice (CHL2 line) encode full-length Htt with 150
polyQ either in a single allele (heterozygous, Hdh150/+) or in both
alleles (homozygous, Hdh150/150) (Lin et al. 2001). The wild-type
littermates of these knock-in mice are hereafter designated by
Hdh+/+.
Isolation
Mitochondria were isolated from mouse forebrain (brain minus
cerebellum). The cerebellum was excluded as it is usually not
involved in HD pathology (Vonsattel and DiFiglia 1998). Similar to
previous studies about mitochondrial Ca2+-loading capacity in HD
transgenic mice (Panov et al. 2002; Brustovetsky et al. 2005),
percoll gradient centrifugation (Sims 1990) was used to prepare
non-synaptosomal mitochondria (see Appendix S1 for details).
Mitochondrial Ca2+ accumulation and membrane potential
Mitochondria (0.2 mg of protein) were suspended in 2 mL of
incubation buffer (10 mmol/L NaCl, 90 mmol/L KCl, 20 mmol/L
HEPES pH 7.2, 0.1% fatty acid free bovine serum albumin (BSA),
5 mmol/L succinate, 2 mmol/L Na2HPO4, 0.2 mmol/L ADP and
5 lg/mL oligomycin) containing TMRM+ at 1 lmol/L (quench
mode, Chalmers and Nicholls 2003) and 0.2 lmol/L CaG5 N for
simultaneous monitoring of respective changes in mitochondrial
membrane potential (Dwm) and extra-mitochondrial Ca2+ concen-
tration ([Ca2+]e). Paired experiments were performed at 37C using
two alternating stirred cuvettes in the automated four-position turret
of a Perkin-Elmer LS-50B ﬂuorimeter (Wellesley, MA, USA).
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CaCl2 infusions were performed at a steady rate of 21 nmol/mg/min
with a Braun Perfusor (FT Scientiﬁc Instruments, Glos., Tewksbury,
UK) modiﬁed to take a pair of 100 lL Hamilton microsyringes
(Zoccarato and Nicholls 1982). CaG5 N was excited at 506 nm and
emission collected at 532 nm. Changes in Dwm were followed
qualitatively by the ﬂuorescence quenching of TMRM+ (549 nm
excitation, 575 nm emission).
Cultured striatal neurons
Cell culture
Primary striatal cultures were generated from the offspring of
crosses between two heterozygous Hdh150 mice or between a
heterozygous male and a wild-type female from the same genetic
background (C57BL/6 J). Brains from E16-17 embryos were
rapidly removed into ice-cold Hank’s balanced salt solution, while
tails and livers were collected for PCR genotyping (Fig. S1a). The
genotyping procedure, requiring DNA puriﬁcation, was not sufﬁ-
ciently fast to allow for brain pooling. Therefore, the entire culture
procedure was performed in parallel for individual brains, resulting
in ‘single-embryo striatal cultures’ plated blindly to genotype.
Brieﬂy, striata were dissected, minced with a scalpel and dissociated
with 0.25% trypsin-EDTA. After enzyme inhibition with 10% heat-
inactivated fetal bovine serum in Neurobasal medium, cells were
plated onto 8-well chambered coverglasses (LabTek, Naperville, IL,
USA) at a density of 2.5 · 105 cells per well, or onto 22 · 40-mm
glass coverslips at a density of 1 · 106 cells per coverslip. The glass
was previously coated with 33 lg/mL polyethyleneimine. Cultures
were maintained in Neurobasal medium supplemented with 1%
glutamax, 2% B27, 1% fetal bovine serum, 100 U/mL penicillin and
0.1 lg/mL streptomycin. Two days after plating, 10 lmol/L
cytosine arabinoside was added to inhibit growth of glial cells.
After 4 days in vitro (DIV), cells were fed by replacing half the
culture media. At 9 DIV glucose was added to a ﬁnal concentration
of 15 mmol/L using a 1.6 mol/L stock solution. Cultures were
maintained at 37C in a 95/5% air/CO2 incubator and used for
experiments at 10–13 DIV. Normal and mutant Htt expression in
neuronal cultures was conﬁrmed by western blotting (Fig. S1b).
Cell respirometer
Measurements of oxygen uptake by intact coverslip-attached
neurons using a ‘cell respirometer’ were previously described in
detail (Jekabsons and Nicholls 2004). Brieﬂy, 22 · 40-mm cover-
slips with attached neurons were mounted in a perfusion chamber
(RC-30; Warner Instruments, Hamden, CT, USA) coupled to two
miniature polarographic Clark-type oxygen electrodes (Microelec-
trodes Inc., Bedford, NH, USA) monitoring the oxygen tension of
the solution entering and exiting the chamber. Perfusion media was
composed by (in mmol/L): 120 NaCl, 3.5 KCl, 0.4 KH2PO4, 1.3
CaCl2, 5 NaHCO3, 1.2 Na2SO4, 20 TES, 15 glucose, 10 pyruvate,
0.4% fatty acid free BSA, pH 7.4 at 37C.
Functional confocal microscopy
Single-cell imaging of neurons, plated in 8-well Lab-Tek chambers,
was performed in a Zeiss Pascal confocal Axiovert 100 M inverted
microscope (Thornwood, NY, USA) using a 20 · air objective (at
0.7 zoom) and argon (488 nm) and helium-neon (543 nm) lasers.
For the simultaneous monitoring of changes in intracellular Ca2+
concentration ([Ca2+]i) and Dwm, cells were loaded with 0.5 lmol/L
Fluo-5F AM, Kd(Ca
2+) = 2.3 lmol/L, and 50 nmol/L TMRM+
(quench mode, Nicholls and Ward 2000) for 30 min at 37C in
incubation buffer containing (in mmol/L): 120 NaCl, 3.5 KCl, 0.4
KH2PO4, 1.3 CaCl2, 20 TES, 5 NaHCO3, 1.2 Na2SO4, 15 glucose
(pH 7.4). At the end of the incubation, cells were washed thrice with
fresh incubation buffer containing 50 nmol/L TMRM+ with glucose
replaced by 10 mmol/L pyruvate in order to accentuate the
mitochondrial role in the maintenance of Ca2+ homeostasis.
Experiments were performed in this buffer at 37C. Cells were
excited at 488 nm for Fluo-5F (emission 505–530) and at 543 nm
for TMRM+ (emission > 560 nm). Individual cell somata were
identiﬁed as regions of interest for the determination of ﬂuorescence
time-courses. NMDA receptor activation was achieved with
100 lmol/L NMDA/10 lmol/L glycine in the absence of Mg2+.
After 10 min, MK801 (5 lmol/L) was added to block receptor
activation and allow for neuronal recovery.
Results
Mitochondrial Ca2+-loading capacity from different
Huntington’s disease mouse models during steady
Ca2+-infusion
In this study, we compare the Ca2+-loading capacity of
forebrain mitochondria isolated from different transgenic HD
mice (R6/2, YAC128 and Hdh150 knock-in) and respective
wild-type littermates. Mitochondrial Ca2+-loading capacity
was estimated by a continuous Ca2+-infusion procedure
(Zoccarato and Nicholls 1982), avoiding the bioenergetic
demands that result from Ca2+-bolus addition. Also, a diluted
mitochondrial suspension was used (0.1 mg/mL) to avoid
premature propagation of the permeability transition (pre-
mature PT) by a sub-population of susceptible mitochondria
releasing sufﬁcient Ca2+ to trigger a ‘chain-reaction’ over-
load and PT in adjacent mitochondria, which may cause to
underestimate the Ca2+-loading capacity of the overall
population (Chalmers and Nicholls 2003). Real-time changes
in extramitochondrial Ca2+ concentration, [Ca2+]e, and Dwm
were simultaneously monitored throughout the experiments.
Addition of mitochondria to the incubation medium
reduces [Ca2+]e, as the residual cation in the media is taken
up by the organelle, and decreases TMRM+ ﬂuorescence
because of probe uptake and quenching in the matrix
(Fig. 1a). The onset of Ca2+-infusion (at 21 nmol/mg/min)
increases [Ca2+]e into a plateau, as the Ca
2+ accumulating
activity of the mitochondrial uniporter gets in balance with
both the infusion rate and the mitochondrial Ca2+-efﬂux
pathway (Zoccarato and Nicholls 1982; Chalmers and
Nicholls 2003). Mitochondria continuously accumulate
Ca2+, buffering [Ca2+]e, until a steep rise occurs (Fig. 1a).
This steep [Ca2+]e rise reﬂects the occurrence of PT in the
mitochondrial population and is delayed approximately
twofold if 1 lmol/L cyclosporin A is present (not shown).
When compared to the [Ca2+]e rise, the increase in TMRM
+
ﬂuorescence is earlier and less steep. This is because in the
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course of Ca2+ infusion a fraction of the mitochondria
undergoes early PT, collapsing Dwm, decreasing the aggre-
gate matrix volume and causing Ca2+ and TMRM+ release
(and thus TMRM+ dequenching, which increases its ﬂuor-
escence). While Ca2+ release is buffered to a speciﬁc set-
point by uniporter reuptake into the polarized mitochondria,
the reuptake of TMRM+ is governed by Nernst equilibrium
and hence does not match what is released by the fraction of
the mitochondria undergoing early PT because of the
decrease in aggregate matrix volume (Chalmers and Nicholls
2003). Thus, the assessment of mitochondrial Ca2+-loading
capacity by monitoring the rise in [Ca2+]e (Fig. 1a) is a better
estimate of the overall mitochondrial population, than the
monitoring of the distribution of Dwm sensitive probes such
as TMRM+.
A comparison of mitochondrial Ca2+-loading capacity for
different HD mouse models is shown in Fig. 1b. Irrespective
of the genetic background, mitochondria from wild-type
mice exhibit a similar Ca2+-loading capacity (316 ± 15,
323 ± 37 and 305 ± 11 nmol/mg for the wild-type litter-
mates of R6/2, YAC128 and Hdh150 knock-in mice,
respectively (Fig. 1b – white bars). Interestingly, mitochon-
dria from both R6/2 and YAC128 mice present an increased
Ca2+-loading capacity (386 ± 27 and 454 ± 10 nmol/mg for
R6/2 and YAC128, respectively; *p < 0.05 vs. wild-type
littermates). This effect is not apparent in Hdh150 knock-in
animals where Ca2+-loading capacities were similar to wild-
type littermates (294 ± 11 and 284 ± 21 nmol/mg, for het-
erozygous and homozygous animals, respectively). It should
be noted that R6/2 mice at 12 weeks, as used in the present
study, are resistant to quinolinic acid injection in the striatum
(Hansson et al. 2001), and both cortical and striatal
mitochondria have increased glutathione levels (Choo et al.
2005), compatible with the observed increase in mitochond-
rial Ca2+-loading capacity, in agreement with previous
ﬁndings (Brustovetsky et al. 2005). Also, YAC128 mice at
the age used in the present study (12 months) present
cortical and striatal atrophy associated with striatal neuronal
loss (Slow et al. 2003), and cognitive dysfunction (Van
Raamsdonk et al. 2005), supportive of ongoing HD neuro-
pathology and hence compatible with our observation of
abnormal mitochondrial Ca2+-handling.
In contrast, knock-in HD mice usually have less wide-
spread pathology than other genetic HD models (Hickey and
Chesselet 2003). Hdh150/150 and less frequently Hdh150/+
mice have behavioral and gait abnormalities starting at
15 weeks of age (Lin et al. 2001), suggesting ongoing HD
neuropathology at the age used in the present study (15–
17 weeks). To the best of our knowledge, there are no
previous studies with brain mitochondria from Hdh150
knock-in mice. However, abnormalities in striatal but not
cortical mitochondria Ca2+-handling have been reported at
12 weeks for other knock-in mice with shorter Htt polyQ
tracts (Brustovetsky et al. 2005). Hence, it is possible that
the mixed neuronal glial population of the forebrain might
have concealed a dysfunction selective for striatal neurons in
Hdh150 knock-in mice. Therefore, and having in mind the
faithful reproduction of the HD genotype in knock-in mice
(Hickey and Chesselet 2003), we studied in situ mitochond-
rial function in cultured striatal neurons from these mice.
In situ mitochondrial respiration in striatal neurons from
Hdh150/+ knock-in mice and wild-type littermates
Using a cell respirometer (Jekabsons and Nicholls 2004), we
monitored in situ mitochondrial respiration of intact cover-
slip-attached striatal neurons from heterozygous Hdh150
knock-in mice (Hdh150/+) and wild-type (Hdh+/+) littermates
(Fig. 2). In each experiment, we compared an Hdh+/+ with an
Hdh150/+ from the same litter. We tested three pairs of
littermates (n = 3 experiments), each pair deriving from a
different litter. Four respiratory rates were measured: basal
(Vbasal), maximal uncontrolled respiration in the presence of
9 lmol/L FCCP (VFCCP), oligomycin (0.2 lg/mL)-insensitive
(Voligo), and residual non-mitochondrial respiration (Vrot/myx)
in the presence of 1 lmol/L rotenone plus 2 lmol/L mixo-
thiazol (oligomycin maintained after Voligo assessment).
The in situ mitochondrial respiration accounts for 91%
of basal respiration [(Vbasal ) Vrot/myx)/Vbasal = 90.7 ± 0.4%
(a) (b)
Fig. 1 Ca2+-loading capacity of forebrain mitochondria isolated from
Huntington’s disease mice. Simultaneous monitoring of mitochondrial
Ca2+accumulation with Calcium Green 5 N (CaG5 N) and mitoch-
ondrial membrane potential with tetramethylrhodamine methyl ester
(TMRM+) was performed as described under Materials and methods.
(a) Representative tracings are from an experiment with YAC128
mitochondria. Tracings obtained with mitochondria from other experi-
mental groups were qualitatively similar. Addition of mitochondria
(arrow) leads to the uptake of residual Ca2+ and TMRM+ quenching in
the matrix. After signal stabilization, CaCl2 was continuously infused at
a steady rate of 21 nmol/mg/min. Mitochondria accumulate Ca2+ until
the onset of permeability transition (PT, estimated by the interception
of the dotted lines), evidenced by a steep [Ca2+]e rise. AU, arbitrary
units. (b) Mean ± SEM of mitochondrial Ca2+-loading capacity, n = 4
for all experimental groups, except n = 2 for Hdh+/+ and Hdh150/150
mice. Mitochondria from wild-type (WT) mice of the three different
background strains present similar Ca2+-loading capacities (white
bars). Mitochondria from either R6/2 or YAC128 mice (but not from
Hdh150/+ or Hdh150/150 mice) accumulate more Ca2+ compared with the
respective WT littermates (*p < 0.05, paired t-test).
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for Hdh+/+ and 90.5 ± 2.2% for Hdh150/+]. In the basal state,
mitochondria are respiring only at about 1/5 of maximal
capacity [(Vbasal ) Vrot/myx)/(VFCCP ) Vrot/myx) = 19.3 ± 1.1%
for Hdh+/+ and 23.5 ± 1.6% for Hdh150/+]. Also, only a
minor percentage of the total ATP generating capacity is used
in the basal state [(Vbasal ) Voligo)/(VFCCP ) Voligo) ¼
9.8 ± 1.3% for Hdh+/+ and 14.4 ± 1.8% for Hdh150/+], with
approximately half of the basal mitochondrial respiration
driving H+ leaks across the mitochondrial inner membrane
[(Voligo ) Vrot/myx)/(Vbasal ) Vrot/myx) = 55.0 ± 3.7% for Hdh
+/+
and 45.8 ± 3.2% for Hdh150/+].
In situ mitochondria from both genotypes show high
pseudo-respiratory control ratios [(state 3 FCCP/state 4) =
(VFCCP ) Vrot/myx)/(Voligo ) Vrot/myx) = 9.50 ± 0.22 for Hdh
+/+
and 9.38 ± 0.03 for Hdh150/+]. Thus, at this young age,
the presence of a single mutant allele encoding Htt in the
Hdh150/+ mice does not signiﬁcantly impair mitochondrial
respiration, at least in resting striatal neurons. Still, it cannot
be excluded that the trend for a higher basal respiration and
ATP turnover, as well as for a smaller maximal respiratory
capacity in Hdh150/+ neurons may represent early signs of
dysfunction.
Susceptibility to NMDA-receptor activation of striatal
neurons from Hdh150 knock-in mice
Having observed no major effect of mutant Htt expression on
mitochondrial respiration of resting Hdh150/+ striatal neurons,
we asked whether challenging of in situ mitochondria with
energy-demanding stimuli, such as high [Ca2+]i, might reveal
differences unapparent under resting conditions. To address
this question, we assessed the ability of striatal neurons to re-
establish neuronal homeostasis following transient NMDA-
receptor (NMDAR) activation (Fig. 3). NMDAR activation
leads to massive Ca2+-entry, threatening neuronal survival.
Mitochondria play an important role in the maintenance of
neuronal homeostasis, both by taking up Ca2+ and synthes-
izing ATP required for energy-dependent homeostatic mech-
anisms. To accentuate this mitochondrial role, we performed
experiments in media with pyruvate (10 mmol/L) instead of
glucose. Under these conditions, neurons depend on ATP
derived solely from oxidative phosphorylation, thus accen-
tuating the bioenergetic consequences of mitochondrial
dysfunction. Indeed, if mitochondrial Ca2+-uptake and ATP
synthesis are prevented (treatment with 1 lmol/L rotenone
plus 2 lg/mL oligomycin), striatal neurons fail to recover
from NMDAR activation (not shown).
Changes in neuronal homeostasis were estimated by the
dynamic monitoring of changes in [Ca2+]i and Dwm by
ﬂuorescence microscopy with Fluo-5F and TMRM+. A
10 min challenge with 100 lmol/L NMDA / 10 lmol/L
glycine, followed by receptor blockade with 5 lmol/L
(5R,10S)-(+)-5-methyl-10,11-dihydro [A,D] cyclohepten
-5,10-imine hydrogen maleate, permitted the distinction
between striatal neurons able to re-establish cellular home-
ostasis (‘recovery’) and those that underwent intracellular
Ca2+ deregulation associated with Dwm collapse (‘deregula-
tion’), a condition that is well correlated with necrotic cell
Fig. 2 In situ respiration of mitochondria in striatal neuronal cultures
from Huntington’s disease mice. Monitoring of oxygen uptake by intact
coverslip-attached cells was performed as described under Materials
and methods to determine: (a) basal respiration, (b) reserve
ATP-generating capacity, (c) respiration supporting ATP turnover, (d)
respiration driving mitochondrial H+ leak, and (e) non-mitochondrial
respiration. Basal respiration was determined prior to perfusion with
9 lmol/L carbonylcyanide-p-(trifluoromethoxyphenyl) hydrazone
(FCCP) to assess maximal respiration. After 1 h of recovery in
standard buffer, cells were sequentially perfused with 0.2 lg/mL
oligomicyn (oligo) and with 1 lmol/L rotenone plus 2 lmol/L myxo-
thiazol (rot/myx). At the end of the experiment, the downstream oxy-
gen electrode received buffer bypassing the chamber (open shunt) to
correct for electrode drift and assess nonmitochondrial respiration.
Results are mean ± SEM of three independent experiments.
(a) (b)
Fig. 3 Susceptibility to NMDA receptor (NMDAR) activation in
pyruvate media of striatal neurons from Hdh150 knock-in mice. Sim-
ultaneous monitoring of changes in neuronal [Ca2+]i with Fluo-5F and
mitochondrial membrane potential with tetramethylrhodamine methyl
ester (TMRM+) was performed as described under Materials and
methods. (a) Representative tracings of single neurons exhibiting
‘recovery’ (left) or ‘deregulation’ (right), following NMDAR activation
(see Results for a detailed description). AFU, arbitrary fluorescence
units. (b) Each circle represents the percentage of neurons that
exhibited ‘deregulation’ in cultures from different embryos (white cir-
cles, Hdh+/+, n = 5; gray circles, Hdh150/+, n = 6) deriving from three
different litters. Hdh150/+ neurons were more prone to undergo
‘deregulation’ than Hdh+/+ neurons (*p < 0.05, unpaired t-test). Black
triangles are two separate determinations using two sister cultures
from the same homozygous (Hdh150/150) embryo.
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death (Nicholls and Budd 2000; Fig. 3a). For each experi-
ment, we analyzed the responses from 250 individual
neurons and calculated the percentage unable to recover
from NMDAR activation, i.e., exhibiting ‘deregulation’
(Fig. 3b).
Expression of mutant huntingtin increases the proportion
of striatal neurons unable to recover from NMDAR activa-
tion. 11.9 ± 0.5% of wild-type (Hdh+/+, 1250 neurons
analyzed) versus 21.0 ± 2.8% of heterozygous Hdh150
knock-in striatal neurons (Hdh150/+, 1500 neurons analyzed)
exhibit ‘deregulation’ following NMDAR activation (ﬁve vs.
six embryos from three different litters; *p < 0.05 unpaired
t-test with Welch’s correction for unequal variances; Fig. 3b).
Obtaining homozygous Hdh150 embryos (Hdh150/150)
with wild-type littermates was a difﬁcult task as it required
the mating of two heterozygous animals and the killing of
pregnant transgenic females. In addition, not all heterozy-
gous · heterozygous crosses yielded homozygous progeny.
We managed to collect functional data from two separately
assayed sister cultures from the same Hdh150/150 embryo and
observed a percentage of 44.8 ± 4.4% of striatal neurons
(500 neurons analyzed) exhibiting ‘deregulation’ following
NMDAR activation. It is noteworthy that this percentage is
higher than in any of the individual experiments performed
with neurons from Hdh+/+ and Hdh150/+ embryos, and that
the entire neuronal culture procedure and plating was blinded
to genotype.
Discussion
Here, we have assessed the Ca2+-loading capacity of isolated
forebrain mitochondria from three different transgenic HD
mice. Using experimental conditions that prevent premature
PT propagation by mitochondrial sub-populations, i.e., the
use of low mitochondrial concentrations and the inclusion of
adenine nucleotides in the incubation, we ﬁnd that wild-type
mitochondria from three different genetic backgrounds
present similar Ca2+-loading capacities. In contrast, Ca2+-
loading capacity is increased in forebrain mitochondria
isolated from R6/2 and YAC128 HD mice, but not in those
from Hdh150 knock-in mice with less severe pathology.
When focusing on neurons selectively targeted by HD, we
ﬁnd that moderate mutant Htt expression, in Hdh150/+ striatal
neurons, does not signiﬁcantly impair in situ mitochondrial
respiration. However, when in situ mitochondria are chal-
lenged with high Ca2+ by transient NMDAR activation,
mutant Htt expression is associated with a higher proportion
of striatal neurons failing to re-establish Ca2+ homeostasis.
We conclude that in order to understand more deeply how
mitochondrial function is affected in HD, studies need to be
conducted not only with isolated mitochondria but also with
in situ mitochondria.
Functional assays with HD mitochondria have mostly
been performed with the isolated organelle (Panov et al.
2002; Choo et al. 2004; Brustovetsky et al. 2005). As
isolation removes mitochondria from the cytoplasm, extra-
polations to in vivo HD are limited. Moreover, as
non-synaptosomal brain preparations (Panov et al. 2002;
Brustovetsky et al. 2005) are inevitably contaminated with
glial mitochondria and are depleted in synaptic mitochondria,
both neuronal-selective and synaptic dysfunction will be
obscured. Hence, despite considerable progress, several
fundamental questions raised by isolated mitochondria
studies remain unsettled or yet to be addressed by studying
in situ HD mitochondria.
Considering the conﬂicting results previously obtained
with isolated HD mitochondria (Panov et al. 2002; Choo
et al. 2004; Brustovetsky et al. 2005), the effects of mutant
Htt on mitochondrial Ca2+-handling are still debatable.
Brustovetsky et al. (2005) reported an age-dependent
increase in the Ca2+-loading capacity of striatal but not of
cortical mitochondria isolated from HD mice. In no instance
did Brustovetsky et al. (2005) observe a decreased Ca2+-
loading capacity for HD mitochondria, in contrast to earlier
reports for HD brain mitochondria and for liver and
lymphoblast HD mitochondria (Panov et al. 2002; Choo
et al. 2004). The approximately 3–6-fold variation in
mitochondrial concentration between these studies is note-
worthy [0.16 mg/mL (Brustovetsky et al. 2005) vs. 0.5 mg/
mL (Panov et al. 2002) and 1 mg/mL (Choo et al. 2004)],
because high concentrations increase the possibility that a
minor subset of susceptible mitochondria might trigger early
PT in the overall population, underestimating the Ca2+-
loading capacity of the major population. Our present data,
using a slow Ca2+-infusion into a diluted (0.1 mg/mL)
mitochondrial suspension to minimize this premature PT
propagation, are consistent with an increased Ca2+-loading
capacity in the overall HD mitochondria population. Hence,
at least for HD brain mitochondria, the opposing results
could be reconciled assuming that the majority of the
population does acquire enhanced resistance to Ca2+ loads
(Brustovetsky et al. 2005), but that they include a small yet
vulnerable fraction that can trigger premature PT in the
population if high mitochondrial concentrations are used
(Panov et al. 2002). While a deleterious interaction with
mutant Htt may explain why some HD mitochondria are
more vulnerable to Ca2+ (Panov et al. 2002, 2003), possible
reasons behind the ‘population resistance’ are less straight-
forward. Increased mitochondrial resistance may result from
adaptive responses to a stressful environment, as previously
proposed (Brustovetsky et al. 2005).
An apparent increase in brain mitochondria resistance to
Ca2+ over-load could derive from the fact that isolated brain
mitochondria are an inevitable mixture of neuronal and glial
mitochondria and that these mitochondria differ (Bambrick
et al. 2004; Kristian et al. 2005). As neuronal loss in HD is
accompanied by glial proliferation (Myers et al. 1991), a
decreased neuron/glia ratio could account for increased
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resistance of the mitochondrial population without adaptive
changes in individual mitochondria. Indeed, neuronal loss
and/or gliosis have been described for several HD mouse
models (Reddy et al. 1998; Lin et al. 2001; Slow et al. 2003;
Yu et al. 2003), but even non-lethal neuronal atrophy by
itself could decrease the neuron/glia mitochondria ratio if the
number of mitochondria per neuron decreases. Development
of assays that allow a reliable and independent analysis of
neuronal and glial mitochondria Ca2+-handling is essential to
resolve this issue. So far, the only method that allows the
isolation of pure neuronal versus glial mitochondria is to use
primary cultures (Kristian et al. 2005).
The present study is, to the best of our knowledge, the ﬁrst
to assess in situ HD mitochondrial respiratory function in
intact (non-permeabilized) coverslip-attached neurons from
transgenic mice. A recent study (Milakovic and Johnson
2005) monitored mitochondrial respiration in immortalized
striatal progenitor cells obtained from wild-type mice
(STHdh+/+ cells, expressing wild-type Htt), and from homo-
zygous knock-in HD mice (STHdh111/111 cells, expressing
mutant Htt with 111 polyQ) (Trettel et al. 2000). The
immortalized cells were permeabilized with digitonin, an
approach that allows the access of non-cell permeant reagents
to the mitochondria inside the cells, permitting a compre-
hensive analysis of mitochondrial respiration but unavoida-
bly leading to dialysis of soluble cytosolic components, and
thus being bioenergetically equivalent to an isolated mitoch-
ondrial preparation.
Milakovic and Johnson (2005) reported that mitochondrial
respiration and ATP production were signiﬁcantly impaired
in STHdh111/111 cells when compared with STHdh+/+ cells,
however, neither signiﬁcant differences were found in the
activity of the mitochondrial respiratory complexes, nor in
the total ATP cellular levels. The authors suggest that in
intact cells, under resting conditions, mitochondria are likely
not to function at maximal capacity and that only under
conditions of neuronal stress would the mitochondrial
impairment contribute to HD pathogenesis. Here we dem-
onstrate that in intact striatal neurons, under resting condi-
tions, mitochondria are indeed working at submaximal
capacity. Furthermore, we show that under neuronal stress
(NMDAR activation), when ATP is deriving solely from the
mitochondria (pyruvate media), expression of full-length
mutant Htt is associated with an increased vulnerability to
Ca2+-deregulation. Our single-cell measurements suggest
that this vulnerability is only restricted to a subset rather than
to a uniform impairment of the neuronal population. This is
consistent with the large in situ mitochondrial spare respir-
atory capacity of the neuronal population expressing mutant
Htt. While no signiﬁcant change in spare respiratory capacity
argues against respiratory chain impairment, defects in ATP
synthesis and/or export in HD neurons cannot be excluded.
Our in situ respiration data contrast with that of Milakovic
and Johnson (2005), ﬁrst by the absence of signiﬁcant
differences in mitochondrial respiration, and second by much
higher respiratory control ratios (RCR) in the present study.
The fact that STHdh111/111 cells express two copies of mutant
Htt versus only one in Hdh150/+ striatal neurons is a likely
explanation for the ﬁrst difference. Indeed, despite HD
patients with two mutant alleles being very rare, evidence
supports that homozygosity is associated with a more severe
clinical course (Squitieri et al. 2003), also, mouse studies
show a clear gene dosage effect (Hickey and Chesselet
2003). As both mutant and wild-type Htt associate with the
mitochondria (Choo et al. 2004), depletion of wild-type Htt
because of homozygosity of the mutation may also play an
important role (Cattaneo et al. 2001; Zhang et al. 2003).
Concerning differences in RCR values, which were £ 4
for the STHdh cell lines (both for state3/state4 or
state3/uncoupled ratios, irrespective of the substrates)
(Milakovic and Johnson 2005) and approximately 9–10 for
striatal neurons in the present study, they may result both
from differences in methodology and in the mitochondrial
origin.
We could not ﬁnd any published RCR data for brain
mitochondria of HD mice. However, they are expected to be
low based on available data from wild-type mouse brain
isolated mitochondria [RCR = 1.6–2.0 (Lobao-Soares et al.
2005); 2.82 ± 0.13 (Xu et al. 2001); > 2 were used in
experiments (Levy et al. 2003); and an exception of
7.5 ± 0.4 (Chavez et al. 1995)]. Interestingly, a comparative
study with rat mitochondria isolated from different tissues
(Rossignol et al. 2000) reported the lowest RCR for the brain
(2.6 ± 1.4), when compared with muscle, heart, liver and
kidney. Signiﬁcantly, mitochondria isolated from cultured rat
neurons with a recently improved methodology presented
RCRs of approximately 9–10 (Kristian et al. 2005). More-
over, our observation of mitochondria respiring at only 1/5
of maximal capacity in the basal state, is consistent with
500% spare respiratory capacity for in situ mitochondria in
synaptosomes (Nicholls and Budd 2000). Thus, it is likely
that in situ neuronal mitochondria present more robust
respiratory properties than commonly isolated brain mito-
chondria.
In summary, the present study shows an overall increase in
the Ca2+-loading capacity of forebrain mitochondria from
R6/2 and YAC128 HD mice. Because of limitations in the
use of isolated non-synaptosomal preparations, it is presently
unclear whether this represents a true mitochondrial resist-
ance or changes in the neuronal/glial mitochondria ratio.
Failure to observe such resistance in Hdh150 knock-in mice
may be related to the slower progression of the disease in
these mice and/or the concealment of a striatal selective
effect in the forebrain mitochondria population. Studies of
mitochondrial respiration in intact heterozygous Hdh150
striatal neurons reveal no signiﬁcant defects in spare
respiratory capacity, basal ATP synthesis, or uncoupling
and do not support a uniform major bioenergetic defect in
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these neurons. Still, when the bioenergetic demand is strong,
such as during NMDAR activation, a select population of
HD striatal neurons may be unable to meet the increased ATP
demand, perhaps because of defects in ATP synthesis/export.
Additional studies, addressing in situ mitochondrial function
in HD neurons and glial cells will be of importance to
understand HD pathogenesis.
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